Page 3 - Rheumatology Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rheumatology research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rheumatology Research Today - Breaking & Trending Today

FDA Approves Secukinumab as First Intravenous Interleukin-17A Antagonist for Rheumatic Diseases

The intravenous formulation of secukinumab is administered in monthly 30-minute, weight-based dosing and requires no pre-medication or lab monitoring. ....

United States , University Of Washington , Christy Siegel , Philipj Mease , Swedish Medical Center , Rheumatology Research , University Of Washington School Medicine , Washington School , Psoriasis Area , Severity Index ,

FDA approves Novartis (NVS) Cosentyx® as first intravenous (IV) formulation interleukin-17A antagonist for rheumatic diseases

FDA approves Novartis (NVS) Cosentyx® as first intravenous (IV) formulation interleukin-17A antagonist for rheumatic diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Philipj Mease , Christy Siegel , Rheumatology Research , Swedish Medical Center , Drug Administration , University Of Washington School Medicine , Clinical Professor , Washington School , Vice President ,

FDA approves Novartis Cosentyx® as first intravenous (IV) formulation interleukin-17A antagonist for rheumatic diseases

FDA approves Novartis Cosentyx® as first intravenous (IV) formulation interleukin-17A antagonist for rheumatic diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Philipj Mease , Eli Lilly , Marlena Abdinoor , Michael Meo , Prnewswire Novartis , Acta Derm Venereol , Sloan Simpson , Christy Siegel , Julie Masow , Dermatol Venereol , Novartis Cosentyx , Drug Administration , Rheumatology Research , Bausch Health , Novartis Pharmaceuticals Corp , Swedish Medical Center , Exchange Commission , Bristol Meyers Squibb Company , University Of Washington School Medicine , Janssen Biotech Inc , Novartis Europharm , Novartis Pharmaceuticals Corporation , Clinical Professor , Washington School , Vice President ,

Lupus Nephritis: Hopes, Questions Arise for Baricitinib

Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of lupus nephritis. ....

United States , South Australia , Ericf Morand , Manal Hassanien , Eli Lilly , European Alliance Of Associations , Therapeutics Department At Assiut University , Monash Health Rheumatology Unit , Rheumatology Research , European Alliance , Advanced Therapeutics Department , Assiut University , Systemic Lupus Erythematosus , Lupus Nephritis , Jak Stat , Ak Stat Signaling Pathway , Ak Stat Cytokine Receptors , End Stage Renal Disease Esrd , End Stage Renal Disease , Rheumatoid Arthritis , Alopecia Areata ,

Study Shifts Burden of IgG4-Related Disease to Women

First population-based US study establishes "key benchmarks" for immune-mediated condition initially described in 2001. ....

United States , Zacharys Wallace , Rheumatology Research Foundation , Clinformatics Data Mart , Medicare Advantage , Massachusetts General Hospital , National Institutes , National Institute , Skin Diseases , Rheumatology Research , Igg4 Syndrome , Mmunoglobulin G4 Related Disease , Igg4 Related Disease , Gg4 Rd , Gg4 Related Systemic Sclerosing Disease , Gg4 Related Sclerosing Disease , Gg4 Related Autoimmune Disease , Gg4 Related Systemic Disease , Gg4 Associated Disease , Gg4 Positive Multiorgan Lymphoproliferative Syndrome , Yper Igg4 Disease , Ystemic Igg4 Related Plasmacytic Syndrome , Ultifocal Fibrosclerosis ,